Detail akcie West Pharm Svc online

Business Summary: West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, West Pharmaceutical Services Inc. revenues increased 2% to $2.95B. Net income before extraordinary items increased 2% to $593.4M. Revenues reflect Contract-Manufactured Products segment increase of 15% to $552.5M, Ireland segment increase of 19% to $285.7M, France segment increase of 19% to $282.9M, Other European Countries segment increase of 8% to $388.1M.